Cargando…

The Impact of Aging, Psychotic Symptoms, Medication, and Brain-Derived Neurotrophic Factor on Cognitive Impairment in Japanese Chronic Schizophrenia Patients

Background: Cognitive impairment in schizophrenia can result in considerable difficulty in performing functions of daily life or social rehabilitation. Cognitive impairment in schizophrenia is related to various factors, such as the psychotic severity, aging, medication, and brain-derived neurotroph...

Descripción completa

Detalles Bibliográficos
Autores principales:	Atake, Kiyokazu, Nakamura, Tomoyuki, Ueda, Nobuhisa, Hori, Hikaru, Katsuki, Asuka, Yoshimura, Reiji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Psychiatry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5987164/ https://www.ncbi.nlm.nih.gov/pubmed/29896133 http://dx.doi.org/10.3389/fpsyt.2018.00232

Ejemplares similares

Effects of Continuing Oral Risperidone vs. Switching from Risperidone to Risperidone Long-Acting Injection on Cognitive Function in Stable Schizophrenia Patients: A Pilot Study
por: Hori, Hikaru, et al.
Publicado: (2018)

Relationships between brain-derived neurotrophic factor, clinical symptoms, and decision-making in chronic schizophrenia: data from the Iowa Gambling Task
por: Hori, Hikaru, et al.
Publicado: (2014)

Serum levels of brain-derived neurotrophic factor (BDNF), proBDNF and plasma 3-methoxy-4-hydroxyphenylglycol levels in chronic schizophrenia
por: Yoshimura, Reiji, et al.
Publicado: (2016)

Serum Brain-Derived Neurotrophic Factor, and Plasma Catecholamine Metabolites in People with Major Depression: Preliminary Cross-Sectional Study
por: Yoshimura, Reiji, et al.
Publicado: (2018)

Catechol-O-methyltransferase Val158Met genotype and the clinical responses to duloxetine treatment or plasma levels of 3-methoxy-4-hydroxyphenylglycol and homovanillic acid in Japanese patients with major depressive disorder
por: Atake, Kiyokazu, et al.
Publicado: (2015)

Risk factors for further sick leave among Japanese workers returning to work after an episode of major depressive disorder: a prospective follow-up study over 1 year
por: Hori, Hikaru, et al.
Publicado: (2019)

Serum Levels of Brain-Derived Neurotrophic Factor at 4 Weeks and Response to Treatment with SSRIs
por: Yoshimura, Reiji, et al.
Publicado: (2014)

Blood Biomarkers Predict the Cognitive Effects of Aripiprazole in Patients with Acute Schizophrenia
por: Hori, Hikaru, et al.
Publicado: (2017)

Influence of fluvoxamine on plasma interleukin-6 or clinical improvement in patients with major depressive disorder
por: Yoshimura, Reiji, et al.
Publicado: (2017)

Adding metoclopramide to paroxetine induced extrapyramidal symptoms and hyperprolactinemia in a depressed woman: a case report
por: Igata, Ryohei, et al.
Publicado: (2016)

Duloxetine, a Selective Noradrenaline Reuptake Inhibitor, Increased Plasma Levels of 3-Methoxy-4-hydroxyphenylglycol but Not Homovanillic Acid in Patients with Major Depressive Disorder
por: Atake, Kiyokazu, et al.
Publicado: (2014)

Effect of blonanserin on cognitive and social function in acute phase Japanese schizophrenia compared with risperidone
por: Hori, Hikaru, et al.
Publicado: (2014)

Increase of plasma brain-derived neurotrophic factor levels in two psychotic depressed patients responding to lithium addition to paroxetine treatment
por: Yoshimura, Reiji, et al.
Publicado: (2007)

Serum proBDNF/BDNF and response to fluvoxamine in drug-naïve first-episode major depressive disorder patients
por: Yoshimura, Reiji, et al.
Publicado: (2014)

Follow-up Study on Electroconvulsive Therapy in Treatment-resistant Depressed Patients after Remission: A Chart Review
por: Tokutsu, Yuki, et al.
Publicado: (2013)

Effect of single caffeine intake on neuropsychological functions in healthy volunteers: A double-blind placebo-controlled study
por: Konishi, Yuki, et al.
Publicado: (2018)

Association Between Serum Insulin-Like Growth Factor 1 Levels and the Clinical Symptoms of Chronic Schizophrenia: Preliminary Findings
por: Okamoto, Naomichi, et al.
Publicado: (2021)

Case report: Impact of hyperthyroidism on psychotic symptoms in schizophrenia comorbid with Graves’ disease
por: Sumi, Yukiyoshi, et al.
Publicado: (2023)

Associations Between the Kynurenine Pathway, Proinflammatory Cytokines, and Brain-Derived Neurotrophic Factor in Hospitalized Patients With Chronic Schizophrenia: A Preliminary Study
por: Okamoto, Naomichi, et al.
Publicado: (2021)

Brain-Derived Neurotrophic Factor and Major Depressive Disorder: Evidence from Meta-Analyses
por: Kishi, Taro, et al.
Publicado: (2018)

Abnormal White Matter Integrity in the Corpus Callosum among Smokers: Tract-Based Spatial Statistics
por: Umene-Nakano, Wakako, et al.
Publicado: (2014)

Gyrification patterns in first-episode, drug-naïve major depression: Associations with plasma levels of brain-derived neurotrophic factor and psychiatric symptoms
por: Natsuyama, Tomoya, et al.
Publicado: (2023)

No Association between the Response to the Addition of an Atypical Antipsychotic Drug to an SSRI or SNRI and the BDNF (Val66Met) Polymorphism in Refractory Major Depressive Disorder in Japanese Patients
por: Yoshimura, Reiji, et al.
Publicado: (2012)

Distinct Differences in Emotional Recognition According to Severity of Psychotic Symptoms in Early-Stage Schizophrenia
por: Won, Seunghee, et al.
Publicado: (2019)

Autoimmune Encephalitis With Psychotic Manifestations and Cognitive Impairment Presenting as Schizophrenia: Case Report and Literature Review
por: Luo, Yuanyuan, et al.
Publicado: (2022)

Schizophrenia, Not a Psychotic Disorder: Bleuler Revisited
por: Loch, Alexandre Andrade
Publicado: (2019)

Editorial: Case reports in schizophrenia and psychotic disorders
por: Tusconi, Massimo, et al.
Publicado: (2023)

Relationship between Brain-Derived Neurotrophic Factor and Schneiderian First Rank Symptoms in Antipsychotic-Naïve Schizophrenia
por: Kalmady, Sunil Vasu, et al.
Publicado: (2013)

The brain-derived neurotrophic factor Val66Met polymorphism increases segregation of structural correlation networks in healthy adult brains
por: Ueda, Issei, et al.
Publicado: (2020)

Differences Between Self-Reported Psychotic Experiences, Clinically Relevant Psychotic Experiences, and Attenuated Psychotic Symptoms in the General Population
por: Moriyama, Tais Silveira, et al.
Publicado: (2019)

Does subjective sleep quality improve by a walking intervention? A real-world study in a Japanese workplace
por: Hori, Hikaru, et al.
Publicado: (2016)

Impaired olfactory function in bipolar disorder patients during acute episodes regardless of psychotic symptoms
por: Li, Yingying, et al.
Publicado: (2023)

Lifetime Prevalence and Correlates of Schizophrenia and Other Psychotic Disorders in Singapore
por: Subramaniam, Mythily, et al.
Publicado: (2021)

Six-month treatment with atypical antipsychotic drugs decreased frontal-lobe levels of glutamate plus glutamine in early-stage first-episode schizophrenia
por: Goto, Naoki, et al.
Publicado: (2012)

Symptom Profiles in Psychotic Disorder Not Otherwise Specified
por: Widing, Line, et al.
Publicado: (2020)

A Metabolomics Study of Serum in Hospitalized Patients With Chronic Schizophrenia
por: Okamoto, Naomichi, et al.
Publicado: (2021)

Continuous decrease in serum brain-derived neurotrophic factor (BDNF) levels in a neuropsychiatric syndrome of systemic lupus erythematosus patient with organic brain changes
por: Ikenouchi-Sugita, Atsuko, et al.
Publicado: (2008)

The Basal Forebrain Cholinergic Nuclei and Their Relevance to Schizophrenia and Other Psychotic Disorders
por: Eickhoff, Sofia, et al.
Publicado: (2022)

Association Between Depressive Symptoms and Serum Brain-Derived Neurotrophic Factor Levels in Patients With First-Episode and Drug-Naïve Schizophrenia
por: Wu, Yuxuan, et al.
Publicado: (2022)

Psychotic Symptoms in Heroin Withdrawal: A Case Report
por: Sharma, Surabhi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_iln4rfs65qhe1o9puo1fouehd2